Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZMIZ2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CD9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PARM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BIRC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HDGFRP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEACAM21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
PKHD1L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NECAB3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MTURN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CABLES1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CRYBB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM230C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FZD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
B4GALT5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TNFAIP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LCP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NUB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
S100A11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on